Continuing Medical Education For HCPs

Staying updated with the latest advancements in cancer health is essential for healthcare professionals. Our Continuing Medical Education (CME) resources offer in-depth insights into the evolving landscape of oncology. Explore a range of educational materials designed to empower medical professionals with the knowledge needed to offer the best possible care to patients dealing with cancer. Stay informed about the latest treatment approaches, research findings, and innovative therapies.

Sponsored By

Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy

RATIONALE: Collecting and storing samples of tissue, blood, and other body fluids to test in the laboratory and gathering information about health and lifestyle from participants may help doctors l ...

Condition: Colorectal Cancer


Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors

The primary purpose of this study is to evaluate the feasibility and safety of MRI-guided focal laser ablation (Laser-Induced Interstitial Thermal Therapy, LITT) to treat low-risk native prostate canc ...

Condition: Prostate Cancer


Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer

The purpose of this study is to test the safety of dacomitinib and osimertinib, at increasing doses, to find out what effects, if any, this combination of drugs has on people with metastatic EGFR muta ...

Condition: Metastatic Non-small Cell Lung Cancer



Radiomic approach to support multidisciplinary tumor board decision-making in locally advanced non-small cell lung cancer

Selecting the optimal treatment for locally advanced non-small cell lung cancer (LA-NSCLC) is complex and typically requires multidisciplinary tumor board (MTB) evaluation. This study investigated whe


Association between intraoperative dexmedetomidine and survival outcomes after colorectal cancer surgery: a retrospective cohort study

The impact of dexmedetomidine (DEX) on postoperative survival outcomes in cancer remains controversial. Our study aimed to investigate the influence of intraoperative DEX administration on postoperati


Cetrorelix promotes cell apoptosis via the PI3K–AKT–FOXO1 pathway in epithelial ovarian cancer

Epithelial ovarian cancer (EOC) has a dismal prognosis, and recent therapeutic advancements have been limited. The aim of our study was to clarify the role and mechanism of cetrorelix in EOC apoptosis



Dr. Sara May, Allergy and Immunology

Enhanced Recovery After Surgery (ERAS) for Colon and Rectal Cancer

Learn about ERAS, Enhanced Recovery After Surgery, for colon and rectal cancer patients.


Dr. Sara May, Allergy and Immunology

Oncogenetics - Mechanism of Cancer (tumor suppressor genes and oncogenes)

Explore how genetic mutations in tumor suppressor genes and oncogenes drive the development of cancer. This video breaks ...


Dr. Sara May, Allergy and Immunology

What Is Nuclear Medicine for Cancer? | ZERO Prostate Cancer & Curium

Presented in partnership with Curium. For more information, visit ...